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I. INTRODUCTION 
The opioid use disorder and overdose crisis continues to challenge our 
agencies, institutions, and the laws underpinning our public health, healthcare, 
and criminal justice systems.1 Recent data from the Centers for Disease Control 
and Prevention indicate that the rates of drug overdose have increased in many 
parts of the country.2 While many overdoses are opioid-related,3 parts of the 
country have seen increases in the use of methamphetamine and cocaine.4 Drug 
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 1 See NICOLAS P. TERRY ET AL., LEGAL AND POLICY BEST PRACTICES IN RESPONSE TO 
THE SUBSTANCE ABUSE CRISIS: A PRELIMINARY REPORT 17–18 (2018), 
https://scholarworks.iupui.edu/bitstream/handle/1805/15972/iu-grand-challenges-
legal-and-policy-best-practices.pdf;jsessionid=B4025DDAC7A9912D51E86AF2F3C 
56D6B?sequence=1 [https://perma.cc/W8JW-ZDUM]. 
 2 Drug Overdose Deaths, CTRS. FOR DISEASE CONTROL & PREVENTION (last updated 
Dec. 19, 2018), https://www.cdc.gov/drugoverdose/data/statedeaths.html [https:// 
perma.cc/PJ5U-B78Y] (outlining the CDC’s findings on drug overdoses). 
 3 Puja Seth et al., Overdose Deaths Involving Opioids, Cocaine, and 
Psychostimulants—United States, 2015–2016, CTRS. FOR DISEASE CONTROL AND 
PREVENTION: MORBIDITY AND MORTALITY WEEKLY REP. (Mar. 30, 2018), 
https://www.cdc.gov/mmwr/volumes/67/wr/mm6712a1.htm?scid=mm6712a1_w 
[https://perma.cc/XU95-K2HC] (discussing the amount of opioid-related overdose deaths 
in the United States). 
 4 Austin Frakt, Overshadowed by the Opioid Crisis: A Comeback by Cocaine,  
N.Y. TIMES (Mar. 5, 2018), https://www.nytimes.com/2018/03/05/upshot/  
overshadowedby-the-opioid-crisis-acomeback-by-cocaine.html [https://perma.cc/ 
498B-4L6F] (elaborating on the surge in cocaine related deaths); Anna Gorman, 
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overdose has now surpassed motor vehicle-related deaths as the leading cause 
of death in many states.5 Overdose deaths are only one of many tragedies 
associated with substance use disorder. Substance use disorder is associated 
with illnesses such as HIV, Hepatitis C, and chronic kidney disease, among 
others.6 
In addition to poor health outcomes experienced by individuals with opioid 
use disorder, the crisis has strained the economy and the criminal justice 
system.7 A 2018 report found that the cost of the opioid crisis from 2001 to 2017 
exceeded $1 trillion in the form of lost wages, lost productivity, lost tax revenue, 
as well as government spending on health care, social services, education, and 
criminal justice.8 A 2013 study found that over a third of this cost comes in the 
form of increased health care expenditures.9 In its civil lawsuit against an opioid 
manufacturer, the State of New Jersey estimated that its Medicaid vendors, 
workers’ compensation program, and employee and retiree health plans have 
spent $290 million in opioid-related costs.10 Similarly, the City of Tacoma 
estimated its spending has increased $10 million a year as a result of the opioid 
crisis.11  
Children and families are also among the victims of the opioid use disorder 
crisis.12 Families are split up when loved ones are in prison for opioid-related 
 
Overshadowed by Opioids, Meth Is Back and Hospitalizations Surge, KAISER HEALTH NEWS 
(Nov. 26, 2018), https://khn.org/news/overshadowed-by-opioids-meth-is-back-and-
hospitalizations-surge/ [https://perma.cc/2TQF-YCA6] (describing the rise of meth 
usage). 
 5 M. Reidhead & L. Porth, A Dangerous Intersection: Drug Overdose Fatalities 
Surpass Motor Vehicle Deaths, MO. HOSP. ASS’N (2018), https://www.mhanet.com/ 
mhaimages/opioid/MVA_v_Opioids/A_Dangerous_Intersectin.pdf  [https://perma.cc/ 
768X-BLKL] (“Throughout the past 16 years, the list of states with more deaths caused by 
drug overdoses than motor vehicles has grown from four to 39.”). 
 6 Eric Sarlin, Substance Use Disorders Are Associated with Major Medical Illnesses 
and Mortality Risk in a Large Integrated Health Care System, NAT’L INST. ON DRUG ABUSE 
(Oct. 24, 2017), https://www.drugabuse.gov/news-events/nida-notes/2017/10/ 
substanceuse-disorders-are-associated-major-medical-illnesses-mortality-risk-in-
large-integrated [https://perma.cc/B2SK-83FX]. 
 7 TERRY ET AL., supra note 1, at 9, 18. 
 8 Economic Toll of Opioid Crisis in U.S. Exceeded $1 Trillion Since 2001, ALTARUM 
(Feb. 13, 2018), https://altarum.org/about/news-and-events/economic-toll-ofopioid-
crisis-in-u-s-exceeded-1-trillion-since-200 [https://perma.cc/RL2A-ZSVM] (reporting 
the current costs of the opioid crisis and projecting future expenditures). 
 9 Curtis S. Florence et al., The Economic Burden of Prescription Opioid Overdose, 
Abuse, and Dependence in the United States, 2013, 54 MED. CARE 901, 901 (2016). 
 10 Complaint at 7, Porrino v. Purdue Pharma, L.P. (N.J. Super. Ct. Ch. Div. Essex 
County Oct. 31, 2017), https://nj.gov/oag/newsreleases17/NJ-Purdue-Complaint_ 
Redacted_final.pdf [https://perma.cc/BH4F-N2WZ]. 
 11 Complaint at 63, City of Tacoma v. Purdue Pharma, L.P., No. 3:17-cv-5737 (W.D. 
Wash. Sept. 13, 2017). 
 12 See generally Yuki Noguchi, Anguished Families Shoulder the Biggest Burdens of 
Opioid Addiction, NPR (Apr. 18, 2018), https://www.npr.org/2018/04/18/602826966/ 
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charges, when individuals are seeking treatment, or after an overdose death.13 
Foster care systems are unable to meet the growing demand of placing children 
in foster care families.14 Indiana, for example, has seen the number of children 
in foster care increase by thousands.15 Many parents with opioid use disorder 
are imprisoned from drug-related criminal charges, which can have downstream 
health effects on their children.16 The Adverse Childhood Experience (ACE) 
Questionnaire is a tool to assess childhood trauma, such as abuse and neglect.17 
High ACE scores are associated with poor health outcomes, including chronic 
disease and early death.18 The questionnaire includes a question on whether the 
child has had a parent in prison,19 a trauma for the child which can lead to 
increased risk of substance use disorder.20 
The root causes of the opioid use disorder and overdose crisis are complex 
and necessitate comprehensive changes to our social, health care, and criminal 
justice systems, which would take significant time to implement.21 Yet there are 
interventions that can be implemented to curb overdoses and other poor health 
 
anguished-families-shoulder-the-biggestburdens-of-opioid-addiction [https://perma. 
cc/P2LL-FJVG] (explaining how opioid addiction tears apart families in the United States). 
 13 See id.; Laura Radel et al., Substance Use, the Opioid Epidemic, and the Child 
Welfare System: Key Findings from a Mixed Methods Study, U.S. DEP’T HEALTH & HUM. 
SERVS. 3 (Mar. 7, 2018), https://aspe.hhs.gov/system/files/pdf/258836/SubstanceUse  
ChildWelfareOverview.pdf [https://perma.cc/KG2V-W8VZ] (“Higher rates of overdose 
deaths and drug hospitalizations correspond with higher child welfare caseload rates.”). 
 14 Scott Simon, The Foster Care System Is Flooded with Children of the Opioid 
Epidemic, NPR (Dec. 23, 2017), https://www.npr.org/2017/12/23/573021632/the-
foster-care-system-is-flooded-with-children-of-the-opioidepidemic [https://perma.cc/ 
6K3R-8F2S] (describing difficulties in placing and affording the number of children 
entering the system). 
 15 Id. 
 16 See About Adverse Childhood Experiences, CTRS. FOR DISEASE CONTROL & 
PREVENTION (Apr. 9, 2019), https://www.cdc.gov/violenceprevention/childabuseand  
neglect/acestudy/aboutace.html [https://perma.cc/ZNM4-Z7QH]; Adverse Childhood 
Experience (ACE) Questionnaire, NAT’L COUNCIL JUV. & FAM. CT. JUDGES, https://www. 
ncjfcj.org/sites /default/files/Finding%20Your%20ACE%20_Score.pdf  [https://per 
ma.cc/LG7C-ULGP] [hereinafter ACE Questionnaire]. 
 17 See ACE Questionnaire, supra note 16. 
 18 Id. 
 19 Id. 
 20 The Role of Adverse Childhood Experiences in Substance Abuse and Related 
Behavioral Health Problems, SAMHSA’S CTR. FOR APPLICATION PREVENTION 
TECHS., https://www.cambridgema.gov/CDD/Projects/Planning/~/media/328D3B716
A24449D8504357BD3865949.ashx [https://perma.cc/7KM2-ZBCL]. 
 21 See generally Nabarun Dasgupta et al., Opioid Crisis: No Easy Fix to Its Social and 
Economic Determinants, 108 AM. J. PUB. HEALTH 182 (2018) (proposing suggestions to 
address the structural problems causing the opioid crisis); Nicolas P. Terry, Structural 
Determinism Amplifying the Opioid Crisis: It’s the Healthcare, Stupid!, 11 NE. U. L. REV. 
315 (2019) (discussing the failings of the healthcare system in relation to the opioid 
epidemic). 
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outcomes associated with substance use immediately.22 Namely, harm 
reduction. 
Harm reduction refers to public health strategies that seek to minimize the 
injury and illness associated with substance use, as opposed to eliminating 
substance use itself.23 For example, in the context of opioid use, harm reduction 
strategies can include increased naloxone training and availability to prevent 
overdose24 or establishing syringe service programs to allow people who inject 
drugs to have access to unused syringes, thereby reducing their risk of 
transmission of HIV, Hepatitis C, and skin infections25 from the sharing and 
reuse of needles.26  
Harm reduction strategies have seen increased prominence in the United 
States as the opioid overdose crisis unfolded. But implementation has been 
inconsistent and fragmented in some jurisdictions without adequate policy 
development to ensure their efficacy.27 This Article argues that it is long 
overdue for harm reduction strategies to be legalized with enabling authorities 
to ensure they are effective in practice.  
Part I provides background on harm reduction by describing select harm 
reduction strategies and the evidence base for them. Part II discusses the status 
of harm reduction in the United States by describing four harm reduction 
strategies in more detail. It discusses how the legal frameworks for these 
strategies could be improved in some jurisdictions. Part III concludes by 
outlining changes in law that are necessary to legalize harm reduction that would 
create a path towards legalization of drugs.  
 
 22 Reducing the Harm of Drug Use and Dependence, UNITED NATIONS OFF. ON DRUGS 
& CRIME: TREAT NET, https://www.unodc.org/ddt-training/treatment/VOLUME%20D/ 
Topic%204/1.VolD_Topic4_Harm_Reduction.pdf [https://perma.cc/E8RP-RSBJ]. 
 23 Id.  
 24 Daniel Kim et al., Expanded Access to Naloxone: Options for Critical Response to 
the Epidemic of Opioid Overdose Mortality, 99 AM. J. PUB. HEALTH 402, 405 (2009). 
 25 See generally John R. Ebright & Barbara Pieper, Skin and Soft Tissue Infections in 
Injection Drug Users, in 16 INFECTIOUS DISEASE CLINICS OF NORTH AMERICA 697 (Robert 
C. Moellering, Jr. ed., 2002) (discussing the skin infections drug users may experience due 
to a combination of tissue trauma, the drug itself, and bacteria). 
 26 See, e.g., Holly Hagan et al., Reduced Risk of Hepatitis B and Hepatitis C Among 
Injection Drug Users in the Tacoma Syringe Exchange Program, 85 AM. J. PUB. HEALTH 
1531, 1531 (1995); Don C. Des Jarlais et al., HIV Incidence Among Injecting Drug Users in 
New York City Syringe-Exchange Programmes, 348 LANCET 987, 987 (1996); Gregg S. 
Gonsalves & Forrest W. Crawford, Dynamics of the HIV Outbreak and Response in Scott 
County, IN, USA, 2011–15: A Modelling Study, 5 LANCET e569, e569 (2018), 
https://www.thelancet.com/pdfs/journals/lanhiv/PIIS2352-3018(18)30176-0.pdf 
[https://perma.cc/XE2J-EVG3]; Alex Wodak & Annie Cooney, Effectiveness of Sterile 
Needle and Syringe Programming in Reducing HIV/AIDS Among Injecting Drug Users, 
WHO (2004), https://www.who.int/hiv/pub/prev_care/effectivenesssterileneedle.pdf  
[https://perma.cc/R4N5-QYLU] [hereinafter Wodak & Cooney]. 
 27 TERRY ET AL., supra note 1, at 20–21 (explaining how piecemeal implementation has 
impacted the state of Indiana). 
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II. UNDERSTANDING HARM REDUCTION 
The origins of modern harm reduction in the United States are rooted in the 
prohibition and criminalization of drugs.28 As drug use went underground to 
avoid criminal liability, individuals who used drugs and their allies needed to 
establish methods to utilize these substances safely.29 Particularly following the 
HIV/AIDS epidemic in the 1980s, harm reduction strategies have been 
mainstreamed as effective prevention strategies for infectious disease amongst 
medical and public health communities.30  
Researchers have made distinctions regarding the types and justifications 
for harm reduction strategies.31 A public health model for harm reduction seeks 
to justify these strategies purely from a disease prevention approach.32 A human 
rights model for harm reduction justifies these strategies because drug users are 
deserving of the health care, safety, and freedoms of other members of the 
public, often denied because of the criminalization of drug use.33 
Harm reduction principles have been applied in policies and programs 
outside of illicit drug use, including tobacco use,34 alcohol use,35 and sexual 
health education,36 among others. Within these issues, examples include e-
cigarettes as a tool to reduce the harm of combustible cigarettes,37 wet shelters 
and housing as a tool to limit the health harms of homelessness,38 and 
contraception access and education as a tool to reduce unintended pregnancies 
 
 28 Don C. Des Jarlais, Harm Reduction in the USA: The Research Perspective and an 
Archive to David Purchase, 14 HARM REDUCTION J. 51, 52 (2017), https://harm 
reductionjournal.biomedcentral.com/track/pdf/10.1186/s12954-017-0178-6 [https:// 
perma.cc/3GYD-XK5Q]. 
 29 Gordon Roe, Harm Reduction as Paradigm: Is Better than Bad Good Enough? The 
Origins of Harm Reduction, 15 CRITICAL PUB. HEALTH 243, 243 (2005). 
 30 Id. 
 31 Id. 
 32 Id. at 245; Christopher B.R. Smith, Harm Reduction Hipsters: Socio-Spatial-
Political Displacement and the ‘Gentrification of Public Health’, in CRITICAL APPROACHES 
TO HARM REDUCTION 209, 211–12 (Christopher Smith & Zack Marshall eds., 2016). 
 33 Id. at 223. 
 34 Caitlin Notley et al., The Unique Contribution of E-Cigarettes for Tobacco Harm 
Reduction in Supporting Smoking Relapse Prevention, 15 HARM REDUCTION J. 31, 31 
(2018), https://harmreductionjournal.biomedcentral.com/track/pdf/10.1186/s12954-
018-0237-7 [https://perma.cc/G6NF-7ATH]. 
 35 G. Alan Marlatt & Katie Witkiewitz, Harm Reduction Approaches to Alcohol Use: 
Health Promotion, Prevention, and Treatment, 27 ADDICTIVE BEHAVS. 867, 867 (2002).  
 36 Karen Mary Leslie, Harm Reduction: An Approach to Reducing Risky Health 
Behaviours in Adolescents, in 13 PAEDIATRIC CHILD HEALTH 53, 53 (2008), 
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2528824/pdf/pch13053.pdf  [https:// 
perma.cc/M7D9-UFE8]. 
 37 Notley et al., supra note 34, at 31. 
 38 Tina Rosenberg, The Shelter that Gives Wine to Alcoholics, GUARDIAN (Apr. 26, 
2016), https://www.theguardian.com/society /2016/apr/26/homeless-shelterottawa-
gives wine-to-alcoholics [https://perma.cc/6XGA-FW8C]. 
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and sexually transmitted infections.39 Harm reduction acknowledges that it is 
impossible to eliminate all health harms and instead seeks to reduce the harms 
associated with an activity.40  
Harm reduction strategies have been studied extensively in the context of 
drug use, particularly injectable drug use, largely due to the HIV crisis in the 
1980s but also due to the current opioid crisis facing the United States.41 
Examples of selected harm reduction strategies used to respond to the opioid 
epidemic and their evidence base are outlined below.  
A variety of harm reduction strategies are available to fight the opioid crisis. 
Syringe service programs (SSPs), for example, gained prominence in the 1980s 
to reduce the spread of HIV among people who inject drugs (PWID).42 These 
programs provide a location where PWID can securely dispose of used syringes 
and secure unused syringes without cost for future use.43 SSPs also often 
provide other resources and services such as safe injection practices and 
linkages to treatment.44 Importantly, SSPs are often one of the few locations 
where PWID can come as they are without judgment or stigma.45 The evidence 
base for syringe service programs spans several decades.46 Areas with syringe 
service programs have seen a reduction of bloodborne disease transmission, 
such as HIV and Hepatitis C.47 Amongst PWID, evidence indicates that there is 
a reduction in the injection-related risk behaviors, such as sharing syringes, and 
a decrease in the number of times a syringe was reused.48 SSPs have also served 
as a vehicle to link individuals with substance use disorder (SUD) to other 
services, including initiating treatment.49 From a funding standpoint, 
investments in SSPs are less costly than the alternative of providing healthcare 
 
 39 Leslie, supra note 36, at 53, 55. 
 40 Id. at 53. 
 41 Des Jarlais, supra note 28. 
 42 See generally Don C. Des Jarlais, Mathilde Krim, AmfAR, and the Prevention of HIV 
Infection Among Injecting Drug Users: A Brief History, 20 AIDS PATIENT CARE & STDS 
467 (2006). 
 43 Syringe Exchange Programs—United States, 2008, CTRS. FOR DISEASE CONTROL & 
PREVENTION: MORBIDITY & MORTALITY WKLY. REP. (Nov. 19, 2010) 
https://www.cdc.gov/mmwr/preview/mmwrhtml/mm5945a4.htm?s_cid=mm5945a4w 
[https://perma.cc/Q59Y-SBB9] (explaining the services syringe exchange programs can 
provide to people who inject drugs).  
 44 Id.  
 45 TERRY ET AL., supra note 1, at 29. 
 46 See Wodak & Cooney, supra note 26, at 5. 
 47 See, e.g., Hagan et al., supra note 26, at 1531. 
 48 Monita R. Patel et al., Reduction of Injection-Related Risk Behaviors After 
Emergency Implementation of a Syringe Services Program During an HIV Outbreak, 77 J. 
ACQUIRED IMMUNE DEFICIENCY SYNDROMES 373, 373 (2018) (“Sterile syringe access as part 
of comprehensive HIV prevention is an important tool to control and prevent HIV 
outbreaks.”). 
 49 Steffanie A. Strathdee et al., Needle-Exchange Attendance and Health Care 
Utilization Promote Entry into Detoxification, 76 J. URB. HEALTH 448, 448 (1999). 
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for HIV and Hepatitis C.50 Those opposed to SSPs state that SSPs lead to higher 
rates of crime and increased drug use;51 however, evidence does not indicate 
that this is the case.52 SSPs also create an environment of compassion and care 
for people who use drugs,53 which can lead to better health outcomes.54 
The primary reason that friends and family members of individuals 
experiencing an overdose avoid contacting emergency services is the fear of 
criminal prosecution for themselves and the person experiencing the overdose.55 
Overdose immunity protections provide criminal immunity from prosecution 
for certain crimes to individuals experiencing an overdose or bystanders to the 
overdose when they contact emergency services.56 Overdose immunity laws 
increase usage of emergency services and prevent overdoses.57  
Naloxone and drug testing kits are other tools to reduce overdose and 
overdose deaths. Naloxone is an overdose reversal drug that can be used to block 
 
 50 Trang Quynh Nguyen et al., Syringe Exchange in the United States: A National Level 
Economic Evaluation of Hypothetical Increases in Investment, 18 AIDS BEHAVS. 2144, 2144 
(2014). 
 51 See, e.g., Curtis Hill, Handing Out Syringes to Addicts Is a Perilous Path, CURTIS 
HILL FOR IND. (Aug. 9, 2019), http://www.curtishillforindiana.com/opinions (scroll to 
opinion and click “Continue Reading”) [https://perma.cc/R5L5-9H88]. 
 52 See generally NAT’L RESEARCH COUNCIL, INST. OF MED., PREVENTING HIV 
TRANSMISSIONS: THE ROLE OF STERILE NEEDLES AND BLEACH (Jacques Normand et al. eds., 
1995) (finding that needle exchange programs do not increase the use of drugs); Melissa A. 
Marx et al., Trends in Crime and the Introduction of a Needle Exchange Program, 90 AM. 
J. PUB. HEALTH 1933, 1934 (2000) (refuting that needle exchange programs raise crime rates, 
with empirical data). 
 53 TERRY ET AL., supra note 1, at 29. 
 54 Kim Sue (@DrKimSue), TWITTER (Feb. 8, 2019), https://twitter.com/DrKimSue/ 
status/1094025140004970497 [https://perma.cc/P2NY- 9Z3X]. 
 55 See Preventing the Consequences of Opioid Overdose: Understanding 911 Good 
Samaritan Laws, SAMHSA’S CTR. FOR APPLICATION OF PREVENTION TECHS. 1, 5 (Nov. 
2017), https://mnprc.org/wp-content/uploads/2019/01/good-samaritan-law-tool.pdf 
[https://perma.cc/64M6-VUQD] [hereinafter Preventing the Consequences of Opioid 
Overdose]; Karin E. Tobin et al., Calling Emergency Medical Services During Drug 
Overdose: An Examination of Individual, Social and Setting Correlates, 100 ADDICTION 397, 
397–98 (2005); see also Zach Myers, Police Urge People to Call 911 to Report Overdoses 
Despite Risk of Arrest, FOX59 (May 15, 2017), http://fox59.com/2017/05/15/police-
urge-911-calls-for-overdoses-despite-risk-of-arrest/ [https://perma.cc/U76N-P4Q3] 
(discussing fears of calling the police in a community where multiple overdoses have 
occurred). 
 56 Good Samaritan Overdose Prevention Laws, PRESCRIPTION DRUG ABUSE POLICY 
SYS. (July 1, 2018), http://pdaps.org/datasets/good-samaritan-overdoselaws-150169 
5153 [https://perma.cc/R977-LF8Z]. 
 57 Chandler McClellan et al., Opioid-Overdose Laws Association with Opioid Use and 
Overdose Mortality, 86 ADDICTIVE BEHAVS. 90, 90 (2018) (showing that Good Samaritan 
laws reduce the amount of opiate overdose deaths). 
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the effects of opioids.58 Improved access to naloxone has resulted in thousands 
of overdose reversals.59 Drug testing kits can be used to test for the presence of 
the highly deadly, synthetic opioid, fentanyl in a drug.60 Test kits allow people 
who use drugs to avoid tainted supplies and prevent overdose.61 As outlined in 
Part II, the laws used to support these harm reduction strategies vary 
significantly from state to state.  
Safe consumption sites, also referred to as overdose prevention sites and 
supervised injection facilities, are locations where people who use drugs can 
consume these drugs in a safe location supervised by trained individuals or 
health care professionals.62 Safe consumption sites have been found to reduce 
incidences of overdose deaths and ambulance calls.63 These facilities reduce 
public injecting and the disposal of syringes in public spaces.64 Not a single 
overdose death has occurred at a safe consumption site.65 
III. HARM REDUCTION LAWS IN THE UNITED STATES 
Much authority for public health interventions lies with state governments 
rather than the federal government.66 States are increasingly passing laws 
 
 58 Information About Naloxone, U.S. FOOD & DRUG ADMIN. (Mar. 7, 2018), 
https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-andprovide 
rs/information-about-naloxone [https://perma.cc/9UNL-83R8]. 
 59 See McClellan et al., supra note 57, at 90. 
 60 Fentanyl, HARM REDUCTION COALITION, https://harmreduction.org/issues/ 
fentanyl/ [https://perma.cc/H5TF-HJJK]. 
 61 Jacqueline E. Goldman et al., Perspectives on Rapid Fentanyl Test Strips as a Harm 
Reduction Practice Among Young Adults Who Use Drugs: A Qualitative Study, 16 HARM 
REDUCTION J. 3, 5 (2019). See generally Olga Khazan, The $1 Tool that Might Curb the 
Overdose Epidemic, ATLANTIC (Oct. 3, 2018), https://www.theatlantic.com/health/ 
archive/2018/10/study-shows-fentanyl-test-stripskeep-addicts-safe/571981/ [https:// 
perma.cc/T6JS-2N2U] (describing the benefits of the use of fentanyl test strips by opioid 
users). 
 62 Supervised Consumption Services, DRUG POL’Y ALL. (Aug. 6, 2018), 
http://www.drugpolicy.org/issues/supervised-consumption-services [https://perma.cc 
/2XLY-TCCY]. 
 63 Jennifer Ng et al., Does Evidence Support Supervised Injection Sites?, 63 CAN. FAM. 
PHYSICIAN 866, 866 (2017). 
 64 See generally Tim Rhodes et al., Public Injecting and the Need for ‘Safer 
Environment Interventions’ in the Reduction of Drug-Related Harm, 101 ADDICTION 1384, 
1388 (2006) (proposing solutions to the danger of public drug-injecting). 
 65 Suchitra Rajagopalan, Providing a Safe Space to Use Drugs Can Help End the 
Overdose Crisis, DRUG POL’Y ALL. (Sept. 10, 2018), http://www.drugpolicy. 
org/blog/providing-safe-space-use-drugs-can-help-end-overdose-crisis [https://perma 
.cc/V4T9-ZXAB]. 
 66 See Richard A. Goodman et al., The Structure of Law in Public Health Systems and 
Practice, in LAW IN PUBLIC HEALTH PRACTICE 45, 58–62 (Richard A. Goodman et al. eds., 
2d ed. 2007). 
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supporting harm reduction strategies, including naloxone access,67 syringe 
service programs,68 and overdose immunity laws.69 Yet, as this section will 
show, there remain many states that have not utilized these strategies, and there 
is much variability in the scope of existing state laws.70 
States that have been the epicenter of the crisis, like West Virginia and 
Indiana, have seen closures of their syringe exchange programs due to pushback 
from policymakers and the community.71 But there has been so much focus on 
just getting harm reduction programming at all that there is a gap in utilizing 
legal strategies to support the effective implementation of these strategies. The 
sections below provide examples regarding the varied implementation of several 
harm reduction approaches. 
A. Syringe Service Programs 
Indiana’s syringe service program law provides an example of an 
inadequate harm reduction law. Following the HIV outbreak in Scott County, 
Indiana,72 Indiana passed a temporary measure to allow for syringe exchange 
programs to operate in the county,73 which was made permanent and extended 
to allow for SSPs across the state.74 The 2015 law allows local governments to 
create syringe service programs following Hepatitis C and HIV epidemics that 
occurred because of injection drug use.75 The law does not allow for the creation 
 
 67 Naloxone Overdose Prevention Laws, PRESCRIPTION DRUG ABUSE POL’Y SYS. (July 
1, 2017), http://pdaps.org/datasets/laws-regulating-administration-of-naloxone-1501 
695139 [https://perma.cc/7FGB-WTGU]. 
 68 See Austin Coleman, Needle Exchange Legality by State, COUNCIL STATE GOV’TS 
(June 25, 2015), http://knowledgecenter.csg.org/kc/content/needle-exchange-legality-
state [https://perma.cc/YPC6-NZWP] (“Sixteen states have passed laws explicitly 
authorizing needle exchange programs, and there are a number of states with statutes that 
either decrease barriers to the distribution of clean needles or altogether remove syringes 
from the list of drug paraphernalia.”). But see Josh Katz, Why a City at the Center of the 
Opioid Crisis Gave Up a Tool to Fight It, N.Y. TIMES (Apr. 27, 2018), 
https://www.nytimes.com/interactive/2018/04/27/upshot/charleston-opioid-crisis-
needle-exchange.html [https://perma.cc/5U9N-EPKN] (discussing the closure of a 
“successful” Charleston needle exchange program, “even as dozens of others have opened”). 
 69 See Good Samaritan Overdose Prevention Laws, supra note 56. 
 70 See infra Parts III.A–D. 
 71 See Katz, supra note 68.  
 72 See Shari Rudavsky, An Indiana Town Recovering from 190 HIV Cases, 
INDIANAPOLIS STAR (Apr. 11, 2016), https://www.indystar.com/story/news/2016/04/08/  
year-after-hiv-outbreak-austin-still-community-recovery/82133598/ [https://perma.cc 
/PUZ8-NXZZ]. 
 73 Press Release, State of Indiana, Needle Exchange for Scott County Only Now in 
Effect (Apr. 4, 2015) (on file with author). 
 74 IND. CODE ANN. § 16-41-7.5 (West Supp. 2015). 
 75 Id. § 16-41-7.5-5. 
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of an SSP in order to prevent an epidemic from occurring, a primary goal of 
public health.76 
Programs are only able to operate for two years at a time.77 In order to keep 
operating, the SSP must secure renewal from the local government.78 This two-
year operation period has led to SSPs shutting down when unable to secure 
political support,79 particularly given the conservative climate within the state.80 
In a state with ninety-two counties,81 only nine counties are operating SSPs.82 
Although Indiana law authorizes the establishment of SSPs, it fails to 
provide sufficient legal protections to make them effective. The Indiana Court 
of Appeals affirmed the conviction of a man for drug paraphernalia possession 
who secured the paraphernalia, a syringe, from an SSP.83 The court said, 
Thus, while [the defendant] could not be prosecuted for obtaining hypodermic 
needles from a needle exchange or participating in a needle exchange program, 
he could be found guilty of possession of paraphernalia if there was evidence 
that he intended to use those syringes for unlawful ends.84 
Neither Indiana’s SSP law nor its drug paraphernalia law provide immunity 
from drug paraphernalia possession for possessing a syringe from an SSP.85 
And, although first-time drug paraphernalia possession is a misdemeanor in the 
state,86 the legislature passed a law escalating syringe possession to a felony in 
2015.87 
 
 76 Id. (allowing a qualified entity to operate a syringe exchange program only if the 
relevant state officials have declared that there is presently an epidemic of Hepatitis C or 
HIV); What Is Public Health?, AM. PUB. HEALTH ASS’N, https://www.apha.org/what-is-
public-health [https://perma.cc/X8JK-2TYM]. 
 77 § 16-41-7.5-11. 
 78 Id. 
 79 See Leigh Hedger, 2nd Indiana County Ends Needle Exchange, with 1 Official Citing 
Moral Concerns, INDIANAPOLIS STAR (Oct. 26, 2017), https://www.indystar.com/ 
story/news/2017/10/23/2nd-indiana-county-ends-needle-exchange-one-official-citing 
-moral-concerns/787740001 [https://perma.cc/UG6K-KF7B] (describing the closure of 
a needle exchange program in Lawrence County after the county prosecutor and state 
attorney general made their objections public). 
 80 See generally Hill, supra note 51. 
 81 County List, IND. DEP’T CHILD SERVS., https://www.in.gov/dcs/3204.htm 
[https://perma.cc/H8SR-SG4Q]. 
 82 Syringe Service Program Providing Counties, IND. ST. DEP’T HEALTH (July 18, 
2018), https://www.in.gov/isdh/files/SSP%20Map%20-%20July%202018-EC.pdf 
[https://perma.cc/7HCW-JVWE]. 
 83 Leatherman v. State, 101 N.E.3d 879, 886 (Ind. Ct. App. 2018).  
 84 Id. 
 85 See IND. CODE ANN. § 16-41-7.5 (West Supp. 2015) (showing that no provision of 
the Syringe Exchange Program includes any criminal immunities); IND. CODE ANN. § 35-48-
4-8.3 (West 2012). 
 86 See § 35-48-4-8.3. 
 87 § 16-42-19-18. 
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Requirements of an emergency, the two-year duration, the risk of criminal 
liability, and the actual prosecution of syringe possession limit the efficacy of 
these programs. Indiana is one of twenty-five states that do not provide criminal 
immunity for possessing drug paraphernalia for the prevention of bloodborne 
infections.88 
B. Overdose Immunity 
Like SSPs, overdose immunity protections are also implemented at the state 
level and vary substantially across jurisdictions.89 In Indiana, immunity is 
provided for the arrest and prosecution of drug and paraphernalia possession.90 
Unlike a jurisdiction like Nevada, which provides protections for violations of 
parole and probation,91 Indiana fails to offer any additional protections.92 And 
Indiana’s protection is only available for the bystander contacting emergency 
services, not the person experiencing the overdose.93 Yet, as outlined above, 
bystanders also fear the criminal prosecution of their loved one and thus avoid 
contacting emergency services.94 Additionally, the bystander can only secure 
the protection if they administer naloxone,95 thus limiting the protection to those 
that have access to the drug. In a February 2019 email to a listserv of public 
defenders in Indiana, one person emailed the group with the subject “calling 911 
for overdose” and asked which statute gave the “fake protection.”96 
Ohio also provides an instructive example. The state’s overdose immunity 
law provides immunity from the arrest, charging, and prosecution of drug 
 
 88 Syringe Distribution Laws, POL’Y SURVEILLANCE PROJECT (July 1, 2017), 
http://lawatlas.org/datasets/syringe-policies-laws-regulating-non-retail-distribution-
of-drug-parapherna [https://perma.cc/4V8Y-E2UJ] (examining the question, “[i]f 
syringes are defined as illegal drug paraphernalia, are there exceptions to the law that would 
allow for the distribution of syringes to prevent blood-borne diseases?” and finding that 
twenty-five states, including Indiana, have no such exception for syringe exchange 
programs). 
 89 See Good Samaritan Overdose Prevention Laws, supra note 56 (showing that, among 
the forty-six states with drug overdose Good Samaritan laws, there is variation both in the 
scope of protections for overdose bystanders and the nature of those protections, e.g., 
immunities, affirmative defenses, or mitigating factors). 
 90 IND. CODE ANN. § 16-42-27-2(g)–(h) (West 2019). 
 91 NEV. REV. STAT. ANN. § 453C.150 (LexisNexis Supp. 2016). 
 92 See Legal Interventions to Increase Access to Naloxone in Indiana Fact Sheet, 
NETWORK FOR PUB. HEALTH L. 2 (Mar. 2018), https://www.networkforphl.org/_asset/tw9 
n11/Overdose-Prevention-Fact-Sheet.pdf [https://perma.cc/4RTK-D2YA] [hereinafter 
Legal Interventions] (stating that the only overdose immunity law for Indiana is contained 
within its law protecting access to overdose intervention drugs). 
 93 § 16-42-27-2(g)–(h). 
 94 See Preventing the Consequences of Opioid Overdose, supra note 55, at 1. 
 95 § 16-42-27-2(g)–(h). 
 96 Posting to Public Defender Council Mailing List, defendnet@lists.in.gov (Feb. 8, 
2019) [on file with Ohio State Law Journal].  
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possession.97 However, the law provides no immunity for drug paraphernalia 
possession.98 Many drugs require paraphernalia in order to be consumed and 
thus the law fails to eliminate the risk of criminal liability, the primary reason 
for which emergency services are not called during an overdose.99  
Some jurisdictions have also prosecuted friends and family members of 
overdose victims for drug-induced homicide if they supplied the drugs that led 
to the overdose.100 Overdose immunity laws fail to provide protections to these 
bystanders against homicide charges.101 
C. Naloxone and Drug Testing Kits 
Naloxone and drug testing kits, such as fentanyl test kits, prevent overdoses 
and overdose deaths.102 Yet, in some jurisdictions, they are considered drug 
paraphernalia, are regularly confiscated by law enforcement, and subject the 
possessor to criminal liability.103 Tennessee, for example, makes it illegal:  
[F]or any person to use, or to possess with intent to use, drug paraphernalia to 
plant, propagate, cultivate, grow, harvest, manufacture, compound, convert, 
produce, process, prepare, test, analyze, pack, repack, store, contain, conceal, 
inject, ingest, inhale, or otherwise introduce into the human body a controlled 
substance or controlled substance analogue in violation of this part.104 
In an effort to promote the use of drug testing kits, some jurisdictions have 
passed laws legalizing their use.105 For example, a recent bill passed in Colorado 
 
 97 OHIO REV. CODE ANN. § 2925.11 (West Supp. 2018). 
 98 Id. § 2925.14.  
 99 See, e.g., Preventing the Consequences of Opioid Overdose, supra note 55, at 5 
(noting that individuals who are aware of Good Samaritan laws may still hesitate to call 
emergency services due to “skepticism and lack of trust” that they will really avoid criminal 
liability). 
 100 Leo Beletsky, America’s Favorite Antidote: Drug-Induced Homicide in the Age of 
the Overdose Crisis, 2019 UTAH L. REV. 833, 873–74 (2019). 
 101 Corey Davis et al., State Approaches to Addressing the Overdose Epidemic: Public 
Health Focus Needed, 47 J.L. MED. & ETHICS 43, 44 (2019). 
 102 Lucas Marten, Investigation: Where Are Naloxone Confiscations Happening the 
Most?, FILTER (Mar. 6, 2019), https://filtermag.org/2019/03/06/investigation-where-are-
naloxone-confiscations-happening-the-most/  [https://perma.cc/B3AJ-BLX6] 
(“[Naloxone] simply saves lives, and has already saved tens of thousands in the US.”); 
Fentanyl Test Strips Prove Useful in Preventing Overdoses, BROWN U. (Oct. 18, 2018), 
https://www.brown.edu/news/2018-10-18/fentanyl [https://perma.cc/CX6S-L5PJ]. 
 103 Marten, supra note 102.  
 104 TENN. CODE ANN. § 39-17-425 (2014). 
 105 S.B. 19-227, 72d Gen. Assemb., 1st Reg. Sess. (Colo. 2019); see, e.g., Council of the 
District of Columbia Votes to Allow Life-Saving Drug Checking Kits, DRUG POL’Y ALL. 
(Dec. 5, 2017), http://www.drugpolicy.org/ press-release/2017/12/council-district-
columbia-votes-allow-life-saving-drug-checking-kits [https://perma.cc/3S4Y 
-7522] (keeping drug testing equipment on the list of prohibited paraphernalia but creating 
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specifies that drug paraphernalia does not include testing equipment to analyze 
a controlled substance.106  
D. Safe Consumption Sites 
Safe consumption sites (SCSs), often referred to as “safe injection 
facilities,” generally serve injectable drug users.107 Safe consumption sites 
provide safe, sterile supplies for drug use.108 The staff, often but not always, are 
healthcare providers that can provide resources and answer questions about 
safer consumption strategies.109 Staff also can provide health care services such 
as first aid, monitoring for overdoses, and administering overdose intervention 
drugs.110 SCSs may link folks to other social services and health care 
services.111  
These sites are legal in various countries around the world, including 
Canada and Germany.112 As numerous local governments across the country 
have begun discussing and planning for establishing safe consumption sites in 
the United States,113 the federal government’s position has been that these sites 
are illegal under federal law.114 Specifically, the U.S. Department of Justice 
 
an exemption for syringe exchange organizations to distribute kits and for individual users 
to check their personal drugs). 
 106 Colo. S.B. 19-227. 
 107 Supervised Consumption Services, supra note 62. 
 108 Leo Beletsky et al., The Law (and Politics) of Safe Injection Facilities in the United 
States, 98 AM. J. PUB. HEALTH 231, 231 (2008). 
 109 Id. 
 110 Id. 
 111 Id.  
 112 Supervised Consumption Services, supra note 62. 
 113 Jessica Cohen, Supervised Injection Facilities Face Obstacles, but that Shouldn’t 
Stop Them, HEALTH AFFAIRS BLOG (Nov. 29, 2018), 
https://www.healthaffairs.org/do/10.1377/hblog20181127.121405/full/  [https://perma 
.cc/9GRR-DGNH]. 
 114 Press Release, Dep’t of Justice U.S. Attorney’s Office District of Colo., Joint 
Statement of the U.S. Attorney’s Office and the Denver Field Office of the Drug 
Enforcement Administration Regarding the City and County of Denver’s Proposal to Create 
Supervised Locations to Inject Heroin and Other Illegal Drugs (Dec. 4, 2018), 
https://www.justice.gov/usao-co/pr/joint-statement-us-attorney-s-office-and-denver-
field-office-drug-enforcement [https://perma.cc/PK7P-M3X9] (stating that there could 
be civil and criminal penalties for “anyone that knowingly opens, leases, rents, maintains, or 
anyone that manages or controls and knowingly and intentionally makes available such 
premises for use”); Press Release, Dep’t of Justice U.S. Attorney’s Office District of Vt., 
Statement of the U.S. Attorney’s Office Concerning Proposed Injection Sites (Dec. 13, 
2017), https://www.justice.gov/usao-vt/pr/statement-us-attorney-s-office-concerning-
proposed-injection-sites [https://perma.cc/326N-KFFE] (stating that safe injection 
facilities “would violate several federal criminal laws, including those prohibiting use of 
narcotics and maintaining a premises for the purpose of narcotics use”). 
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argues that these sites violate the “crack house statute,”115 which prohibits the 
operating of a site where drugs are used.116 At the state level, a safe consumption 
site would be unlawful under existing drug and paraphernalia possession 
laws.117 
The federal government recently sued Safehouse, a Pennsylvania nonprofit 
that seeks to offer overdose prevention services at a safe consumption site,118 
for declaratory relief stating that the operation of an SCS violates federal law.119 
The suit is pending in the U.S. District Court for the Eastern District of 
Pennsylvania.120 In its Answer, Safehouse argues that it is not violating federal 
law because an SCS is a medical and public health facility, distinguishable from 
the crack house targeted by federal law.121 
IV. CONCLUSION 
Upticks in opioid use disorder and overdose over the past decades are 
coupled with increased rates of methamphetamine and cocaine use across 
several communities around the country.122 Clay Marsh, leaning on research 
from Anne Case and Angus Deaton,123 argues that the opioid crisis is a symptom 
 
 115 Alex Kreit, Safe Injection Sites and the Federal “Crack House” Statute, 60 B.C. L. 
REV. 413, 418 (2019). 
 116 21 U.S.C. § 856 (2012). 
 117 Kreit, supra note 115, at 418 (“The United States Attorneys for the districts of 
Colorado, Massachusetts, and Vermont have announced that if safe injection sites were 
established in their states, they would consider bringing criminal charges against facility 
employees.”). 
 118 About, SAFEHOUSE, https://www.safehousephilly.org/about [https://perma.cc/ 
Z34D-NG3E].  
 119 Complaint at 2, United States v. Safehouse, No. 2:19-cv-00519-GAM (E.D. Pa. Feb. 
5, 2019). 
 120 Id. 
 121 Defendant’s Answer at 5, United States v. Safehouse, No. 2:19-cv-00519-GAM 
(E.D. Pa. Apr. 3, 2019). 
 122 See What Is the Scope of Methamphetamine Misuse in the United States? NAT’L INST. 
ON DRUG ABUSE, https://www.drugabuse.gov/publications/research-reports/ 
methamphetamine/what-scope-methamphetamine-misuse-in-united-states [https://per 
ma.cc/VX2B-J65Z] (last updated Apr. 2019) (describing the rise in methamphetamine use); 
Chloe Reichel, Cocaine Use Is on the Rise: Research Highlights Troubling Trends, 
JOURNALIST’S RES. (May 28, 2019), https://journalistsresource.org/studies/society/ 
public-health/cocaine-research-fentanyl-overdose/ [https://perma.cc/U3LZ-8UN4] 
(detailing the recent rise of cocaine use).  
 123 See generally Anne Case & Angus Deaton, Mortality and Morbidity in the 21st 
Century, BROOKINGS PAPERS ON ECON. ACTIVITY 397 (2017), https://www.brook 
ings.edu/wp-content/uploads/2017/08/casetextsp17bpea.pdf [https://perma.cc/H62B-
P4HB] (finding that “mortality and morbidity among white non-Hispanic Americans in 
midlife since the turn of the century continued to climb through 2015” in part due to an 
increase in drug overdoses). 
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of a larger crisis.124 Really, the crisis’s root causes stem from the social 
determinants of health—poverty, education, housing.125 Policies addressing 
these social determinants are complex and require significant policy and system 
change.126 In the meantime, harm reduction measures exist that can save 
lives.127 
While there have been significant increases in states’ legislative action 
supporting harm reduction strategies, many of these laws are narrow in 
application or fail to close loopholes that undermine the efficacy of these laws. 
State legislatures need to ensure that when they legislate on these issues, the 
laws are structured in a way that actually supports these strategies.  
I have previously argued that “there are actionable, discrete, evidence-based 
policy measures” to respond to the opioid overdose crisis that are being 
undermined by ineffective legislation.128 But in fact, harm reduction is not 
simply undermined but instead has not been legalized in many jurisdictions. 
Meaningful changes to harm reduction laws must be made in conjunction with 
social and structural determinants before real improvements to the opioid use 
disorder and overdose crisis are made.  
 
 124 See generally Clay Marsh, Opioid Addiction Isn’t the Disease; It’s the Symptom, 
HUFFPOST (June 16, 2017), https://www.huffpost.com/entry/opioid-addiction-isnt-the-
disease-its-the-symptom_b_59441bc3e4b06bb7d272e3b6 [https://perma.cc/X3N3-
3TXT] (“The answer to our opioid epidemic, then, is the same as the answer to our increasing 
health care spending and reduced health and lifespan of our population. . . . We need strong 
connections to others.”). 
 125 See Dasgupta et al., supra note 21, at 183. 
 126 See id. at 182. 
 127 See supra Parts I, II.  
 128 Aila Hoss, Many State Laws Undermine Harm Reduction Strategies in the Opioid 
Crisis, BILL OF HEALTH: HARV. L. PETRIE-FLOM CTR. (July 20, 2018), 
http://blogs.harvard.edu/billofhealth/2018/07/20/many-state-laws-undermine-harm-
reduction-strategies-in-the-opioid-crisis/ [https://perma.cc/LD76-45YS]. 
 
